11th- 12th November

2nd Annual MarketsandMarkets Biosimilars Virtual Conference

MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Biosimilars Virtual Conference to be held on 11th- 12th November.

Key Highlights
  • Strategic framework and regulatory considerations
  • Key clinical attributes of Biosimilars
  • Expectations of biosimilars by different stakeholders
  • Market access and commercialization
Who Should Attend?

CEO, CSO, CMO, Director, VP, Head, Manager, and Research fellows from pharmaceutical and biotech company working in:

  • Biosimilar Research
  • Biosimilar Development
  • Clinical Development Unit
  • Regulatory Affairs
  • Medical Affairs and information
  • Scientific Affairs
  • Legal Affairs
  • Market Access
  • Licensing
  • Pricing strategy
  • Clinical Pharmacology
  • Clinical affairs/clinical operations
  • Commercial Development
  • Bioanalytics
Why attend?
  • Learn about the recent trends and advancements affecting the biosimilars market
  • Learn about best practices for the commercial structure of a biosimilar from development to market access strategy
  • Engage in meaningful discussion with the most prominent industry experts and decision-makers from pharmaceutical and biopharmaceutical manufactures who will address most critical challenges in biosimilars upstream and downstream process
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators